Episode 234: Amar Kishan, MD, on Neoadjuvant or Adjuvant Radiotherapy for Prostate Cancer

By The Uromigos - Last Updated: August 1, 2023

In the first part of our Hollywood tour, Amar Kishan, MD, joins us to discuss his recent meta-analysis published in the Journal of Clinical Oncology on the effects of concurrent adjuvant sequencing versus neoadjuvant concurrent sequencing. Dr. Kishan also gives an overview of the added benefit that androgen deprivation therapy provides when combined with radiation therapy.
Dr. Kishan is the Vice Chair of Clinical and Translational Research and Chief of GU Radiotherapy at the University of California, Los Angeles.

Post Tags:Uromigos-Prostate Cancer